Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα.

The article presents a case study of a 37-year-old Brazilian man who was receiving treatment with infliximab and has been using adalimumab for ankylosin spondylitis. It cites that the patients was complaining of rhinorrhea and nasal obstruction for 3 months. The article also notes that he was treated with a liposomal amphotericin B, but after seven months after treatment, he returned with complaints of rhinorrhea, nose bleeding and congestion.